Latest Health Science Center Stories
DALLAS, June 12, 2013 /PRNewswire-USNewswire/ -- The University of North Texas System (UNTS) Board of Regents today named Michael R. Williams, DO, MD, MBA, as the sole finalist for the Presidency of the University of North Texas Health Science Center (UNTHSC) in Fort Worth. (Photo: http://photos.prnewswire.com/prnh/20130612/DC31362) UNT System Chancellor Lee F. Jackson recommended Dr. Williams to the Board after receiving a unanimous recommendation from a Presidential Search...
Practices should ask patients questions on initial and subsequent visits By relying on hunches rather than posing a few screening questions, primary care clinicians may be missing three-fourths of the alcohol problems in their patients, a newly released analysis shows. "It's often off the radar — people come in for hypertension and are not asked how much they drink," said study co-author Barbara J. Turner, M.D., M.S.Ed., M.A., M.A.C.P., of UT Medicine San Antonio. Primary care offices...
Behavioral support from peers and primary care office staff can help patients improve their blood pressure control by as much as starting a new drug, a new study found. Barbara J. Turner, M.D., M.S.Ed., M.A., M.A.C.P., of UT Medicine San Antonio, is the senior author. The randomized, controlled trial examined whether six months of intervention — behavioral support from peers and primary care office staff — could benefit African-American patients who had poor control of systolic...
Health Science Center researchers prepare clinical trial that will use fat-enclosed nanoparticles to irradiate just the right spot For the past 40 years, radiation has been the most effective method for treating deadly brain tumors called glioblastomas. But, although the targeting technology has been refined, beams of radiation still must pass through healthy brain tissue to reach the tumor, and patients can only tolerate small amounts before developing serious side effects. A group of...
High blood pressure (hypertension) is a principal risk factor for heart disease and affects 1 billion people. At least half of them are estimated to be salt-sensitive; their blood pressure rises with sodium intake. New research released today [Jan. 22] shows important aspects of how sodium and potassium are regulated in the kidney. The work, posted online by Nature, also offers insight on how one form of familial high blood pressure disease is inherited. Nephrology researchers in the...
Waistlines in people, glucose levels in mice hint at sweeteners' effectsIn the constant battle to lose inches or at least stay the same, we reach for the diet soda. Two studies presented Saturday [June 25] at the American Diabetes Association's Scientific Sessions suggest this might be self-defeating behavior.Epidemiologists from the School of Medicine at The University of Texas Health Science Center San Antonio reported data showing that diet soft drink consumption is associated with...
Cell biologists pondering the death of neurons "” brain cells "” said today that by eliminating one ingredient from the cellular machinery, they prolonged the life of neurons stressed by a pesticide chemical. The finding identifies a potential therapeutic target to slow changes that lead to neurodegenerative disorders such as Parkinson's and Alzheimer's diseases.The researchers, from The University of Texas Health Science Center San Antonio, found that neurons lacking a substance called...
CALGARY, Feb. 14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced preliminary results from a U.S. Phase 2 clinical trial (REO 017) using intravenous administration of REOLYSIN((R)) in combination with gemcitabine (Gemzar((R))) in patients with advanced pancreatic cancer. The trial is being conducted at the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio (CTRC). The Principal...
Plant agents show promise in preventing skin cancerMaybe you worshipped the sun in your youth or weren't as meticulous as you should have been with sunscreen. If so, take heart: Scientists at The University of Texas Health Science Center San Antonio are finding that certain plant substances, when given in combinations, may suppress damage that can cause skin cancer.The substances, which occur naturally in grapes, berries, walnuts and a number of other plant-based foods, were tested on mice...
CALGARY, May 26 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC....
